1088 related articles for article (PubMed ID: 19719543)
21. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
Cady RK; Voirin J; Farmer K; Browning R; Beach ME; Tarrasch J
Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311
[TBL] [Abstract][Full Text] [Related]
22. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial.
Mohammadianinejad SE; Abbasi V; Sajedi SA; Majdinasab N; Abdollahi F; Hajmanouchehri R; Faraji A
Clin Neuropharmacol; 2011; 34(4):174-7. PubMed ID: 21738025
[TBL] [Abstract][Full Text] [Related]
23. Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study).
Gupta P; Singh S; Goyal V; Shukla G; Behari M
Headache; 2007 Mar; 47(3):402-12. PubMed ID: 17371357
[TBL] [Abstract][Full Text] [Related]
24. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
[TBL] [Abstract][Full Text] [Related]
25. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
26. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
[TBL] [Abstract][Full Text] [Related]
27. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety.
Winner P; Gendolla A; Stayer C; Wang S; Yuen E; Battisti WP; Nye JS
Headache; 2006; 46(10):1503-10. PubMed ID: 17115983
[TBL] [Abstract][Full Text] [Related]
28. Tramadol/acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebo-controlled trial.
Silberstein SD; Freitag FG; Rozen TD; Kudrow DB; Hewitt DJ; Jordan DM; Fisher AC; Rosenthal NR;
Headache; 2005; 45(10):1317-27. PubMed ID: 16324164
[TBL] [Abstract][Full Text] [Related]
29. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache.
Limmroth V; Biondi D; Pfeil J; Schwalen S
Headache; 2007 Jan; 47(1):13-21. PubMed ID: 17355489
[TBL] [Abstract][Full Text] [Related]
30. Assessing clinically meaningful treatment effects in controlled trials: chronic migraine as an example.
Dodick DW; Turkel CC; DeGryse RE; Diener HC; Lipton RB; Aurora SK; Nolan ME; Silberstein SD
J Pain; 2015 Feb; 16(2):164-75. PubMed ID: 25464159
[TBL] [Abstract][Full Text] [Related]
31. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.
Bussone G; Diener HC; Pfeil J; Schwalen S
Int J Clin Pract; 2005 Aug; 59(8):961-8. PubMed ID: 16033621
[TBL] [Abstract][Full Text] [Related]
32. Clinical assessment of topiramate therapy in patients with migrainous vertigo.
Gode S; Celebisoy N; Kirazli T; Akyuz A; Bilgen C; Karapolat H; Sirin H; Gokcay F
Headache; 2010 Jan; 50(1):77-84. PubMed ID: 19656221
[TBL] [Abstract][Full Text] [Related]
33. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J;
Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
[TBL] [Abstract][Full Text] [Related]
34. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
[TBL] [Abstract][Full Text] [Related]
36. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
[TBL] [Abstract][Full Text] [Related]
37. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
[TBL] [Abstract][Full Text] [Related]
38. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
Raggi A; Leonardi M; Bussone G; D'Amico D
Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
[TBL] [Abstract][Full Text] [Related]
39. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.
Ashtari F; Shaygannejad V; Akbari M
Acta Neurol Scand; 2008 Nov; 118(5):301-5. PubMed ID: 18713156
[TBL] [Abstract][Full Text] [Related]
40. MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.
Aurora SK; Silberstein SD; Kori SH; Tepper SJ; Borland SW; Wang M; Dodick DW
Headache; 2011 Apr; 51(4):507-17. PubMed ID: 21457235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]